Home
Journal Information
About
Aims and Scope
Editorial Board
Editor in Chief
Open Access
Editorial Office
Editorial Policies
Journal Issues
Current Issue
In Press
All Issues
Contact Us
Create Account
Login
Please don't use dangerous characters
Title
Author
Abstract
Keywords
First Name
Last Name
Search
ISSN
:
2008-5117
eISSN
:
2008-6830
Submit Your Paper
Instructions for Authors
Instructions for Reviewers
Editor in Chief
Editorial Board
Editorial Policies
English Editing Service
Indexing and Abstracting
Archive
Platinum Open Access
This Platinum Open Access journal publishes articles totally free of charge for the authors and provides unrestricted access to the published content through its website and open access repositories such as PubMed Central. All related costs for processing of the manuscripts are sponsored by Tabriz University of Medical Sciences.
Indexing Info
Collaborator of
J Cardiovasc Thorac Res
. 2016;8(2): 56-60. doi:
10.15171/jcvtr.2016.11
PMID:
27489597
PMCID:
PMC4970571
Original Article
Association of serum uric acid level with mortality and morbidity of patients with acute ST-elevation myocardial infarction
Reza Hajizadeh
1
, Samad Ghaffari
1
* , Rezvanieh Salehi
1
, Sarvin Mazani
2
, Sharmin Aghavali
2
Cited by CrossRef: 14
1- Wang H, Yang J, Sao J, Zhang J, Pang X. The prediction of cardiac events in patients with acute ST segment elevation myocardial infarction: A meta–analysis of serum uric acid. 2018;13(1):413
[Crossref]
2- Li Z, Liu Q, Yao Z. The serum uric acid-to-high-density lipoprotein cholesterol ratio is a predictor for all-cause and cardiovascular disease mortality: a cross-sectional study.
Front Endocrinol
. 2024;15
[Crossref]
3- Liang D, Zhu Q, He Y, Lin Q, Feng X, Hu L, Zhou X, Chen C, Huang W, Shan P, Hong X. The interaction between hyperuricemia and low-density lipoprotein cholesterol increases the risk of 1-year post-discharge all-cause mortality in ST-segment elevation myocardial infarction patients.
Nutrition, Metabolism and Cardiovascular Diseases
. 2023;33(1):133
[Crossref]
4- Kim J, Kwon M, Choi H, Lee S, Kim S, Kim J, Kwon B, Lee J. The association between hyperuricemia and cardiovascular disease history: A cross-sectional study using KoGES HEXA data. 2022;101(51):e32338
[Crossref]
5- Yang Y, Zhang J, Jia L, Su J, Ma M, Lin X. The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction.
Front Cardiovasc Med
. 2023;10
[Crossref]
6- Fanning N, Merriman T, Dalbeth N, Stamp L. An association of smoking with serum urate and gout: A health paradox.
Seminars in Arthritis and Rheumatism
. 2018;47(6):825
[Crossref]
7- Rong J, Fang C, Chen X, Hong C, Huang L. Association of serum uric acid with prognosis in patients with myocardial infarction: an update systematic review and meta-analysis.
BMC Cardiovasc Disord
. 2023;23(1)
[Crossref]
8- Mohammed S, Rasool M. The Prognostic Value of Serum Uric Acid in St-Segment Elevation Myocardial Infarction. 2021;18(3):230
[Crossref]
9- Li L, Ma Y, Shang X, Hong Y, Wang J, Tan Z, Wang Y, Geng X. Hyperuricemia is associated with short-term outcomes in elderly patients with acute myocardial infarction.
Aging Clin Exp Res
. 2018;30(10):1211
[Crossref]
10- Shen S, He F, Cheng C, Xu B, Sheng J. Uric acid aggravates myocardial ischemia–reperfusion injury via ROS/NLRP3 pyroptosis pathway.
Biomedicine & Pharmacotherapy
. 2021;133:110990
[Crossref]
11- Demiray A, Afsar B, Covic A, Kuwabara M, Ferro C, Lanaspa M, Johnson R, Kanbay M. The Role of Uric Acid in the Acute Myocardial Infarction: A Narrative Review.
Angiology
. 2022;73(1):9
[Crossref]
12- Li Y, Liu X, Luo Y. Monocyte to high-density lipoprotein cholesterol ratio and serum uric acid in Chinese adults: a cross-sectional study.
BMC Endocr Disord
. 2022;22(1)
[Crossref]
13- 杨 彦. Research Progress of Serum Uric Acid in the Occurrence and Development of Myocardial Infarction.
ACM
. 2022;12(12):11389
[Crossref]
14- Xia C, Zheng Y, Ji L, Liu H. Comparative effectiveness of different interventions on adherence to exercise-based CR among patients after percutaneous coronary intervention: a network meta-analysis of randomized controlled trials.
BMC Nurs
. 2024;23(1)
[Crossref]
15- EKİCİ GÜNAY N, BAKTIR A, ÇAKIR İ, MUHTAROĞLU S, NİSARİ M. Uric acid-lymphocyte ratios and myocardial damage parameters in ST elevated myocardial infarction. 2020;10(1):108
[Crossref]
16- Kajana V, Massaro G, Somaschini A, Cornara S, Demarchi A, Nardella E, Nicoletti A, Sangiorgi G, Mandurino-Mirizzi A. Serum uric acid in patients with ST-segment elevation myocardial infarction: An innocent bystander or leading actor?.
Nutrition, Metabolism and Cardiovascular Diseases
. 2022;32(7):1583
[Crossref]
17- Chen X, You J, Zhou M, Ma H, Huang C. The association between serum uric acid and creatine phosphokinase in the general population: NHANES 2015–2018.
BMC Cardiovasc Disord
. 2023;23(1)
[Crossref]
18- Campbell S, Wiemer H, Fitzpatrick R, Carriere C, Teed S, Hico P, Snook A. A Pilot Study of Inhaled Low-dose Methoxyflurane to Support Cunningham Reduction of Anterior Shoulder Dislocation.
Eurasian J Emerg Med
. 2022;21(4):242
[Crossref]